SciELO - Scientific Electronic Library Online

 
vol.85 issue4Frequency and clinical association of NY-ESO-1 gene expression in diffuse large B-cell lymphomaHelical tomotherapy: advanced radiotherapy technology author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista médica del Hospital General de México

On-line version ISSN 2524-177XPrint version ISSN 0185-1063

Abstract

HIGUERA-DE LA TIJERA, Fátima; SERVIN-CAAMANO, Alfredo  and  PEREZ-HERNANDEZ, José L.. Gastrointestinal symptoms and disorders related to COVID-19. Lessons learned from gastroenterologists. Rev. med. Hosp. Gen. Méx. [online]. 2022, vol.85, n.4, pp.169-178.  Epub Jan 23, 2023. ISSN 2524-177X.  https://doi.org/10.24875/hgmx.22000013.

COVID-19 is mainly a respiratory illness caused by the SARS-CoV-2 but can also lead to GI symptoms. The primary host receptor which mediates the mechanism as SARS-CoV-2 enters the cell is the ACE2 receptor. Therefore, GI symptoms can be common in COVID-19, and in some cases, they are the first manifestation even before fever and respiratory symptoms. In addition, the liver function tests alteration often is related to a worse prognosis. The exact incidence of GI symptoms is a matter of debate. Moreover, wide variation concerning GI symptoms frequency exists, but the predominant ones seem to be diarrhea, anorexia, nausea, vomiting, and abdominal pain or discomfort. This review summarizes the most relevant findings of COVID-19 on the digestive system, including the liver, biliary tract, pancreas, the most common GI symptoms, and the atypical clinical GI manifestations.

Keywords : Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Gastrointestinal symptoms; Pancreatitis; Liver injury; Gastrointestinal bleeding.

        · text in English     · English ( pdf )